| Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping ML Cher, GS Bova, DH Moore, EJ Small, PR Carroll, SS Pin, JI Epstein, ... Cancer research 56 (13), 3091-3102, 1996 | 503 | 1996 |
| Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy ML CHER, FJ BIANCO, JS LAM, LP DAVIS, DJ GRIGNON, WA SAKR, ... The Journal of urology 160 (4), 1387-1391, 1998 | 330 | 1998 |
| CXCL12/CXCR4 signaling activates Akt‐1 and MMP‐9 expression in prostate cancer cells: the role of bone microenvironment‐associated CXCL12 SR Chinni, S Sivalogan, Z Dong, JCT Filho, X Deng, RD Bonfil, ML Cher The Prostate 66 (1), 32-48, 2006 | 304 | 2006 |
| Severe combined immunodeficient-hu model of human prostate cancer metastasis to human bone JA Nemeth, JF Harb, U Barroso Jr, Z He, DJ Grignon, ML Cher Cancer research 59 (8), 1987-1993, 1999 | 285 | 1999 |
| Matrix metalloproteinase activity, bone matrix turnover, and tumor cell proliferation in prostate cancer bone metastasis JA Nemeth, R Yousif, M Herzog, M Che, J Upadhyay, B Shekarriz, ... Journal of the National Cancer Institute 94 (1), 17-25, 2002 | 275 | 2002 |
| Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer ML Cher, D Macgrogan, R Bookstein, JA Brown, RB Jenkins, RH Jensen Genes, Chromosomes and Cancer 11 (3), 153-162, 1994 | 267 | 1994 |
| The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. JS Wolf Jr, M Cher, M Dall'Era, JC Presti Jr, H Hricak, PR Carroll The Journal of urology 153 (3 Pt 2), 993-999, 1995 | 254 | 1995 |
| Loss of let-7 up-regulates EZH2 in prostate cancer consistent with the acquisition of cancer stem cell signatures that are attenuated by BR-DIM D Kong, E Heath, W Chen, ML Cher, I Powell, L Heilbrun, Y Li, S Ali, ... PloS one 7 (3), e33729, 2012 | 251 | 2012 |
| Cathepsin B and tumor proteolysis: contribution of the tumor microenvironment BF Sloane, S Yan, I Podgorski, BE Linebaugh, ML Cher, J Mai, ... Seminars in cancer biology 15 (2), 149-157, 2005 | 215 | 2005 |
| Lycopene and soy isoflavones in the treatment of prostate cancer U Vaishampayan, M Hussain, M Banerjee, S Seren, FH Sarkar, J Fontana, ... Nutrition and cancer 59 (1), 1-7, 2007 | 209 | 2007 |
| Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis ML Cher, HR Biliran Jr, S Bhagat, Y Meng, M Che, J Lockett, J Abrams, ... Proceedings of the National Academy of Sciences 100 (13), 7847-7852, 2003 | 202 | 2003 |
| Platelet-derived growth factor-D overexpression contributes to epithelial-mesenchymal transition of PC3 prostate cancer cells D Kong, Z Wang, SH Sarkar, Y Li, S Banerjee, A Saliganan, HRC Kim, ... Stem Cells 26 (6), 1425-1435, 2008 | 197 | 2008 |
| Circulating tumor cells: finding the needle in the haystack X Zhe, ML Cher, RD Bonfil American journal of cancer research 1 (6), 740, 2011 | 176 | 2011 |
| Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1 … M Toth, MM Bernardo, DC Gervasi, PD Soloway, Z Wang, HF Bigg, ... Journal of Biological Chemistry 275 (52), 41415-41423, 2000 | 175 | 2000 |
| PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling MK Conley-LaComb, A Saliganan, P Kandagatla, YQ Chen, ML Cher, ... Molecular cancer 12, 1-10, 2013 | 168 | 2013 |
| CXCL12/CXCR4 transactivates HER2 in lipid rafts of prostate cancer cells and promotes growth of metastatic deposits in bone SR Chinni, H Yamamoto, Z Dong, A Sabbota, RD Bonfil, ML Cher Molecular Cancer Research 6 (3), 446-457, 2008 | 162 | 2008 |
| Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer EL Gheiler, MV Tefilli, R Tiguert, D Grignon, ML Cher, W Sakr, JE Pontes, ... Urology 51 (5), 789-795, 1998 | 154 | 1998 |
| Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-κB (RANK)/RANK ligand … Y Li, O Kucuk, M Hussain, J Abrams, ML Cher, FH Sarkar Cancer research 66 (9), 4816-4825, 2006 | 151 | 2006 |
| Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue Z Dong, RD Bonfil, S Chinni, X Deng, JC Trindade Filho, M Bernardo, ... The American journal of pathology 166 (4), 1173-1186, 2005 | 138 | 2005 |
| Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein Y Li, M Che, S Bhagat, KL Ellis, O Kucuk, DR Doerge, J Abrams, ML Cher, ... Neoplasia 6 (4), 354-363, 2004 | 130 | 2004 |
